Cargando…
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
This review focuses on the emerging monoclonal antibody market for infectious diseases and the metric ton scale manufacturing requirements to meet global demand. Increasing access to existing antibody-based products coupled with the unmet need in infectious disease will likely exceed the current exi...
Autores principales: | Whaley, Kevin J, Zeitlin, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103258/ https://www.ncbi.nlm.nih.gov/pubmed/34259613 http://dx.doi.org/10.1080/21645515.2021.1930847 |
Ejemplares similares
-
Inhaled antibodies: Quality and performance considerations
por: Hickey, Anthony James, et al.
Publicado: (2021) -
Antibody-dependent passive protection of mucosal surfaces
por: Mestecky, Jiri
Publicado: (2021) -
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
por: Tharmalingam, Tharmala, et al.
Publicado: (2021) -
The biophysical principles underpinning muco-trapping functions of antibodies
por: Schaefer, Alison, et al.
Publicado: (2021) -
Special focus issue: passive immunization
por: Zeitlin, Larry, et al.
Publicado: (2022)